Adjuvant treatment for breast cancer may result in long-lasting, adverse emotional and physical side effects, and reduce quality of life (QOL). This pilot study examined the effects of a home-based walking program on QOL and fatigue in early stage breast cancer survivors and whether changes in walking behavior were associated with changes in outcomes. Methods: Participants (n = 32) were randomized to a 12-week home-based walking intervention plus brief telephone counseling (n = 20) or a wait-list control group (n = 12). Self-reported fatigue, QOL, and walking were assessed at baseline and 12-weeks. Results are presented as effect sizes. Results: Participants in the intervention had improvements in a majority of fatigue and QOL outcomes, whereas the control group had no change or worsened in many; effect sizes were generally in the small to medium range. Changes in fatigue/QOL outcomes were associated with changes in walking behavior, with effects generally in the small to medium range. Conclusion: Home-based physical activity (walking) programs may be an appropriate avenue for alleviating the adverse side effects that often accompany adjuvant treatment for breast cancer. These programs have potential for widespread dissemination, which may have considerable impact on the quality of life of women recently completing breast cancer treatment.
According to most recent national estimates, approximately 226,870 new cases of invasive breast cancer are expected to be diagnosed among women in 2012, and approximately 39,510 women are expected to die of breast cancer. 1 Improvements in breast cancer treatment and early detection 2 have contributed to the steady decrease in breast cancer mortality rates since 1990; 1 5-year survival rates for women diagnosed with breast cancer are 90%. 1 In 2008, approximately 2.6 million women in the United States with a history of breast cancer were alive. 3 Although advancements in treatment have increased survival of women with breast cancer, the treatments themselves (eg, chemotherapy, radiation) may cause adverse emotional and physical side effects, and reduce quality of life (QOL). 4, 5 The high prevalence and survival rates of breast cancer in women warrants increased public health efforts in ameliorating the adverse effects of treatment on QOL. In addition, the fear of recurrence is common among breast cancer survivors as they transition from 'patient' to 'survivor.' 6 Following adjuvant treatment, breast cancer survivors may be more willing and open to make lifestyle behavior changes, perhaps in an effort to alleviate their fears of recurrence. 7 This period of willingness and openness presents an opportune time for public health professionals to intervene and promote positive behavior change, which may lead to improvements in well-being and QOL.
There is emerging evidence on the beneficial effects of physical activity on functional and psychological well-being in breast cancer patients and survivors. 8, 9 Unfortunately, physical activity levels in women have been shown to decrease during treatment for breast cancer. [10] [11] [12] In addition to considering the typical barriers to physical activity that arise with the general population, interventions promoting physical activity in women who have recently completed treatment for breast cancer need to consider the physical and emotional obstacles that accompany adjuvant treatment (eg, fatigue, pain). A home-based program that focuses on an easy form of physical activity such as walking, and where women are encouraged to incorporate (bouts of) physical activity into their existing lifestyle may be more appropriate and realistic for this population.
While physical activity has been shown to improve QOL and fatigue following treatment for breast cancer, most studies to date have been highly controlled, where exercise sessions are supervised and/or take place at a gym. 13 Unfortunately, only a limited number of studies [14] [15] [16] have examined the feasibility of unsupervised, homebased, lifestyle approaches. Such approaches, if effective, have the potential to be widely disseminated at a lower cost, perhaps resulting in meaningful improvements in the health of a vulnerable and growing population. The purpose of this randomized controlled pilot study was to examine the effects of a 12-week, home-based walking program on QOL and fatigue in early stage breast cancer survivors. A secondary purpose was to examine whether changes in these outcomes were related to changes in walking behavior. We hypothesized that women in the walking program would show greater improvements in QOL and fatigue than women in the control group, and that changes in these outcomes would be associated with changes in walking behavior.
Material and Methods

Study Design and Eligibility Criteria
The Breast Cancer Walking Study was a randomized controlled trial that evaluated the effects of a 12-week home-based walking
Participant Recruitment
Participants were recruited from the Palmetto Health Cancer Center (Columbia, SC) with the assistance of the Psychosocial Oncology program. Personnel at Palmetto Health generated a list of women that that may have met initial eligibility criteria and sent it to the tumor registry to obtain information on treatment and surgery dates as well as stage of disease. Individuals who were still deemed potentially eligible were sent a letter from Palmetto Health on behalf of the principal investigator from University of South Carolina introducing the study, as well as a brochure and mail-back card. Follow-up calls were made to all potentially eligible participants. Those who remained interested in participating in the study at the end of the call were scheduled for their baseline appointment.
Randomization and Intervention
During the baseline appointment, all participants completed an informed consent form that was approved by the institutional review boards of the University of South Carolina and Palmetto Health. Participants also provided consent to use/disclose information from their medical records pertaining to their cancer diagnosis (research authorization form). Upon providing consent, participants were screened to ensure eligibility. After completing baseline measures, participants were randomized to a home-based walking intervention or a usual care control group. Participants were randomized 2:1 (intervention:control). This decision was made to maximize the ability to test the intervention, while also having a control group, given the financial constraints of a pilot study.
Women randomized to the intervention (Table 1 ) completed a 12-week home-based walking program using the Active Choices model developed and refined by King and colleagues. 17 The primary purpose of the intervention was to increase walking. Participants received a brief (~30 minute) in-person counseling session, followed by 5 short (10-15 minutes each) telephone counseling calls in weeks 1, 2, 4, 7, and 10. The counseling was delivered by 2 trained public health doctoral students (one student delivered a majority of the counseling). The initial one-on-one counseling session focused on goal setting and exercise safety. The subsequent counseling calls applied key constructs of the social cognitive theory, 18 where the counselor and participants discussed a specific behavior change principle (eg, social support, rewards) that participants could use to increase their walking. A semistructured script was used during each call to initiate discussion with participants about whether they met their previously established walking goals. Participants not meeting their walking goals were asked about the barriers they encountered and worked with the counselor to problem solve ways around them. The counseling call ended with discussion of the new walking goal, and the next counseling call was scheduled. The telephone counseling calls were also designed to monitor participant safety and enhance adherence to the walking program. Each call asked participants about any injuries, pain, discomfort, or soreness they experienced since the previous intervention contact.
Pedometers and physical activity logs were given in an effort to encourage self monitoring. Each day, women recorded minutes of activity (walking), daily pedometer steps, rating of perceived exer-tion (RPE) during activity, and heart rate during activity (optional). The completed self-report activity logs were mailed back to study staff each month. The walking prescription was designed so that there was a gradual increase in the frequency, duration, and intensity. In week 1, participants were instructed to walk 3 days for 20 minutes at a moderate intensity (RPE 10-11). If participants could do more based on their initial fitness level, they were encouraged to do so. By week 8, participants were instructed to walk 5 days a week for 30 to 40 minutes at moderate to vigorous intensity (RPE 12-15), and maintain that level of walking for the remainder of the study.
Women randomized to the usual care control group were asked to maintain their usual physical activity levels throughout the 12-week study period. Study staff only had contact with this group at the follow-up appointments. Upon completion of the study, women in the usual care control group received the baseline intervention counseling session, materials, and pedometer.
Clinic Visits/Measures
Approximately 10 to 12 days before the scheduled baseline and 12-week visits, participants were sent a packet of questionnaires to complete. Participants brought the questionnaires with them and study staff checked for completeness. Physical measures were taken by trained study staff during the clinic visit.
Demographic and Health-Related Variables.
Participants were asked to self-report their age, marital status, race, and highest grade or year of education completed. Participants also rated their general health status on a scale from 1 (excellent) to 5 (poor). Height and weight were obtained by trained staff. Body mass index (BMI) was calculated as kg/m 2 using standard procedures. Medical information concerning diagnosis and treatment (ie, dates, surgery, treatments) were obtained via self-report and medical record review.
Quality of Life. QOL was assessed using 2 measures. The Medical Outcomes 36-item Short Form Health Survey (SF-36) 19 contains 8 individual subscales that represent the 3 general areas of healthrelated QOL: physical, emotional, and well-being. Each subscale is standardized on a scale from 0 to 100, with higher scores indicating higher functioning. Two additional scales, the physical and mental component summary scales, were also scored. This measure has been shown to be reliable and valid. 20, 21 The International Breast Cancer Study Group (IBCSG) QOL Core Questionnaire is a breast cancer specific questionnaire, developed to measure the impact of adjuvant therapy on QOL. 22 The questionnaire consists of 10 single-item visual analog scales, anchored at both ends with words describing the highest and lowest extremes of the item content. Scores (0-100) were coded so that a higher score indicates better QOL. The feasibility, validity, and clinical relevance of this measure has been previously established. 22 Fatigue. The 13 item subscale of the Functional Assessment of Cancer Therapy: Fatigue (FACT-Fatigue) 23 questionnaire was used to assess fatigue. This instrument uses a scale of 1 (not at all) to 5 (very much) to assess multiple fatigue characteristics and their impact on function. A lower score indicates less fatigue. This measure has been shown to be reliable and valid. 23 Physical Activity (Walking). Participants completed the 41-item, validated 24 Community Health Activities Model Program for Seniors (CHAMPS) questionnaire. 25 Three items assess energy expenditure from walking for exercise. Participants reported the frequency (times per week) and duration (total time per week using a 6-item scale ranging from "less than 1 hour a week" to "9 or more hours per JPAH Vol. 12, Suppl. 1, 2015
week") in which they walked or hiked uphill, walked leisurely for exercise or pleasure, and walked fast or briskly for exercise in the past 4 weeks. Data from these 3 items were converted to walking energy expenditure (MET-hours/week) using MET estimates by Stewart et al. 25 Walking, as measured by the CHAMPS questionnaire has been found to be strongly correlated with walking as measured by the Actigraph in a sample similar to ours (ρ = 0.65, P < .01). 26 
Statistical Analyses
A total of 33 participants were recruited into the study. One participant attended the baseline clinic and completed physical measurements, but did not bring the questionnaires to the visit (we were unable to subsequently attain them), nor did she complete any follow-up measures (clinical or questionnaires). Therefore, she was not included in this study. Basic descriptive statistics included frequencies and means of key study variables for the intervention and control groups separately. Chi squares for categorical variables and t tests for continuous variables examined differences between groups on key variables at baseline.
Repeated measures analysis of covariance using SAS PROC MIXED tested whether there were differences between the intervention and control group on outcomes at 12 weeks (group × time interaction) and were used to estimate adjusted means at both time points. Because there were significant differences in race and radiation treatment between groups, these variables were included as covariates in all models. Because this study was conceptualized as a pilot study and was thus underpowered due to the small sample size, results are presented as effect sizes. The within group effect size for change was calculated for the intervention and control group separately as d = (12 week adjusted mean -baseline adjusted mean) ÷ unadjusted pooled baseline standard deviation. The effect size for differences in change between the intervention and control groups was calculated as d = (mean pre/post adjusted change intervention group -mean pre/post adjusted change control group) ÷ unadjusted pooled baseline standard deviation. 27 Baseline data from all participants was used in calculating effect sizes in analyses examining prepost change in QOL and fatigue outcomes. Using Cohen's effect sizes, 28 d = 0.2 was considered a small effect, d = 0.5 was considered a medium effect, and d = 0.8 was considered a large effect.
To examine whether changes in walking were associated with changes in fatigue/ QOL, residualized change scores were first calculated for walking and each outcome. We then compared 2 models for each residualized outcome: one that contained just radiation and race and a second that added residualized walking score. The differences between the 2 models, or the incremental R 2 (IR 2 ), was computed and compared with conventions described by Cohen 28 as small (R 2 = .01), medium (R 2 = .09), and large (R 2 = .25). The IR 2 represents variance in change in outcome uniquely explained by change in walking.
Results
This study includes 32 participants; 20 women were randomized to the intervention group and 12 women to the control group. Baseline demographic, health-related and medical treatment characteristics by group assignment are shown in Table 1 . Participants in the intervention group were more likely to be white (P = .01) and to report receiving radiation treatment (P = .04) than participants in the control group. Posttest data at 12 weeks was collected on 94% of participants; 2 women in the intervention group dropped out of the study.
Participants, on average, returned 2.6 out of 3 exercise logs; 15 participants (79%) returned all 3 logs, 1 participant (5%) returned 2 logs, and 3 participants (16%) returned 1 log. On average, participants completed 86.2 ± 11.9% (range 62.1% to 100%) of the prescribed walking sessions each week (missing logs were assigned zeros for the number of walking sessions completed in those particular weeks; data not shown).
Baseline and 12-week scores on the FACT-Fatigue questionnaire, the IBCSG QOL Core questionnaire, and the SF-36 questionnaire, as well as the calculated effect sizes for within group and between group change are shown in Tables 2 and 3 . Within group analyses showed that participants in the walking intervention had improvements in fatigue and many aspects of QOL, and with a few exceptions, effects were generally in the small to medium range. In contrast, for those in the control group, with the exception of a few small improvements, fatigue and QOL generally did not change or worsened over time.
Between group analyses showed that participants in the walking intervention experienced greater reductions in fatigue than control participants, and this effect was in the small to medium range (ES = -0.36). The walking intervention resulted in improvements in many indicators of QOL as measured by the IBCSG QOL Core questionnaire. Compared with those in the control group, participants in the walking intervention showed greater improvements in: current health (ES = 0.27) and mood (ES = 0.30), with effects in the small range; physical well-being (ES = 0.38), with effects in the small to medium range; feeling sick (ES = 0.51), appetite (ES = 0.56), and effort in coping (ES = 0.59), with effects in the medium range; and tiredness (ES = 0.68), with effects in the medium to large range. The intervention had no effect on social support (ES = -0.01) or hot flashes (ES = 0.07), and participants in the control group had greater improvements in restricted use of arm, with effects in the medium to large range (ES = -0.65)
The walking intervention also resulted in a number of improvements in aspects of QOL as measured by the SF-36 questionnaire. Participants in the walking intervention had greater improvements than the control group on the following subscales: role-emotional (ES = 0.14) and mental health (ES = 0.28), with effects in the small range; vitality (ES = 0.57) and role-physical (ES = 0.60), with effects in the medium range; and general health (ES = 0.66) and physical functioning (ES = 0.69), with effects in the medium to large range. The walking intervention had no effect on pain (ES = -0.04) or social functioning (ES = 0.04). For the summary scores, participants in the walking intervention had greater improvements than the control group on the mental (ES = -0.16, small effect) and physical components (ES = 0.79, large effect).
Participants in the walking intervention had greater increases in energy expenditure from walking for exercise than the control group (ES intervention = 3.07; ES control = 0.18; ES between group = 2.89). Table 4 shows the association between changes in walking behavior and changes in fatigue and QOL as measured by the IBCSG QOL Core and SF-36 questionnaires. For most outcomes, changes in walking explained a meaningful amount of variance in change in the outcome, with effects typically in the small to medium range. Effects were generally smaller for mental health-related outcomes and greater for physical health-related outcomes. 
Discussion
Advances in treatment and early detection 2 have resulted in high survival rates in women diagnosed with breast cancer. 1 Despite the beneficial effects of physical activity on well-being in breast cancer patients and survivors, 8, 9 physical activity levels decrease during treatment. [10] [11] [12] Public health efforts aimed at alleviating the adverse side effects 4,5 of adjuvant treatment are warranted in an attempt to increase the QOL in the 2.6 million breast cancer survivors. 3 This study found that a home-based, lifestyle physical activity intervention delivered via telephone improved QOL and fatigue in early stage breast cancer survivors. Participants in the walking intervention had improvements in a majority of outcomes, whereas the control group had no change or worsened in many; effect sizes for differences in change between groups were generally in the small to medium range. Increases in walking, which was the mode of physical activity this study focused on, was associated with improvements in many of the outcomes examined. Wide-spread dissemination of a home-based program such as this one could result in meaningful public health improvements in a vulnerable population. Often times adjuvant treatments for breast cancer (eg, chemotherapy, radiation) cause adverse emotional and physical side effects, and reduce QOL. 4, 5 Some of these side effects (eg, pain, fatigue, sleep disturbances, arm symptoms, sexual functioning) may persist a year after treatment ends. 29 Our findings suggest that physical activity may be a viable means for reducing such negative side effects. Clinically significant improvements in a number of aspects of QOL, as measured by the SF-36, were seen at 12 weeks. With the exception of bodily pain, effect sizes for the physical components were in the medium to large range, whereas effects for the mental components were much smaller. Our findings suggest that a home-based walking intervention with telephone counseling may be particularly appropriate for improving physical well-being. It is also important to note that the women in this study were much more impaired on the physical subscales than the emotional subscales at baseline, leaving more room for improvement.
In addition to improvements in general aspects of QOL, increases in breast cancer specific QOL, as measured by the IBCSG QOL Core questionnaire, were found, with effects generally in the small to medium range. This finding is particularly important given the negative effects adjuvant therapy can have. Surprisingly, there was a small to medium negative effect on arm use in the intervention group, where these participants reported more restriction in the use of their arm at 12 weeks. No adverse events, such as incident lymphedema were reported, and we did not take measurement of arm strength or function during the study, so the underlying reason for this result is not clear. While this study focused solely on walking, not upper body exercise or strength training, it is possible that women added in other types of activity, such as housework, which made them more aware of arm restrictions (eg, reaching, lifting). The findings related to QOL are promising, as this was a simple intervention approach, unsupervised, and thus not very costly for the program or women. Promoting walking could be a very costeffective and safe approach that yields meaningful benefits.
Our findings are comparable to the limited number of studies examining the effects of home-based, lifestyle physical activity interventions on QOL. A 12-week, home-based physical activity intervention delivered via telephone to 86 women by Pinto and colleagues 14 resulted in a significant improvement in vigor and a trend toward a beneficial effect on total mood disturbance. A 6-month, group-based lifestyle physical activity intervention delivered to 60 women by Basen-Engquist and colleagues 15 found significant improvements in the bodily pain and general health subscales of the SF-36 and trends for significant effects for the role limitationsphysical and physical functioning subscales. However, they found no significant improvements in any of mental/emotional well-being subscales. Finally, a 12-week print material and pedometer intervention with 377 women by Vallance et al 16 found significant improvements in QOL. Unfortunately, none of these studies reported effect sizes, so we are unable to make direct comparisons of the magnitude of the effect across studies. Caution should also be taken when making comparisons across studies, as the measures of QOL varied.
Fatigue is common during and after treatment for breast cancer, 4, 29 and higher levels of fatigue have been shown to be related to lower QOL. 5 An 18-month longitudinal study by Montazeri and colleagues 29 found that fatigue levels increased sharply 3 months after the initial treatment, and were even higher at the 18-month follow-up (1 year after completing treatment). Over our 12-week intervention there was a decrease in fatigue, with the effect in the small to medium range. As with the QOL results, these findings are promising given this was a simple, low-cost, and low-burden intervention. Our findings are similar to those found in other homebased physical activity interventions mentioned previously. Pinto and colleagues 14 and Vallance and colleagues 16 both found significant decreases in fatigue at the 12 week follow-up (effect sizes not reported in either study).
This study has a number of strengths including its randomized design, the use of valid measures, and the low dropout rate of participants. However, we also recognize study limitations and they should be considered when interpreting our findings. The exclusion of women with cardiovascular disease and major orthopedic limitations, and the inclusion of only early stage breast cancer survivors may limit the generalizabilty of the results. Second, the short duration of the intervention and follow-up period limits our ability to understand the long-term impact of the intervention on QOL and fatigue. Third, it is possible that the attention and encouragement from study staff during the counseling calls and not the physical activity improved QOL and fatigue. However, the association between changes in walking and improvements in QOL and fatigue support the importance of physical activity. Fourth, the findings of our study may be subjected to social desirability bias, where participants in the walking group reported higher QOL and lower fatigue at follow-up simply because they knew they were expected to. Again, the association between changes in walking and improvements in outcomes cast some doubt on this concern. Finally, our sample size was quite small. However, calculating effect sizes allowed us to determine the clinical meaningfulness of the intervention on outcomes, which may be of most importance in a study like this. The purpose of this pilot study was to investigate if a home-based, lifestyle physical activity intervention delivered via telephone was feasible for early stage breast cancer survivors. The results provide preliminary support for the effects of such a study, warranting the development and evaluation of a larger, randomized controlled trial.
Home-based physical activity programs such as the one in this study may be appropriate for breast cancer survivors. Our findings suggest that facility-based exercise training programs and intensive counseling may not be necessary to improve QOL and fatigue in appropriately screened breast cancer survivors. As shown in this study, a home-based walking program, combined with brief telephone counseling, may result in clinically meaningful improvements as well. These findings have important implications; the ultimate goal of public health interventions is to implement efficacious programs into the community that reach and benefit the largest number of people (ie, breast cancer survivors). 14 Similar to Pinto and colleagues intervention, 14 this intervention did not require an exercise facility or supervision during exercise, and it is likely that the brief telephone counseling could be done by trained health educators. This type of program has the potential for widespread dissemination, which may have a considerable impact on the QOL of women who have recently completed breast cancer treatment.
